The Scan

This Week in Nature

Nature reports on genetic discrimination, China's drug industry, histone methylation patterns, and more.

HHMI and JCB go head to head.

Wired ranks the "Best Dangerous Science Jobs."

A VentureBeat article says real personalized medicine won't be with us for a long time, but the early stages of the field took a tiny step forward with a new AIDS drug.

A new study finds a genetic variation linked to ADHD that also predicts which children will outgrow the disorder.

Keith Robison remembers the early days of restriction endonucleases.

Another cloning first: a fourth-generation cloned pig.

Personalized medicine? This article says so-called ethnic drugs don't treat based on true genetic variation among individuals.

Chris Mooney says preconceptions, not critical thinking, drives the Bush administration's stance on science.

A blogger asks for pictures of his readers' science-related tattoos.

Drug companies stand to gain by funding biomedical research.

A blogger links to a ballad on polony sequencing. Forgive us.

Jonathan Eisen blogs on why medical professionals should get more evolution education than most medical schools currently offer.

Scientists recovered 60-million-year-old microbes from an Antarctic glacier -- and woke them up.

Score one for subscription-based publications: this blog post details an open-access trial that didn't work out.

NSF looks set to award IBM a contract to build the world's fastest supercomputer.

Fred Sanger bequeaths his collection of lab notebooks to the Wellcome Trust to make them available to the public.

Despite great funding, an embryonic stem-cell research program in California is having trouble finding a president.

Disgraced stem cell scientist didn't realize he'd made parthenogenic stem cells.

The NIH asks for ideas about peer review.

This Week in Science

Today's Science reports on immunology, patient identifiability in genomic research, synthetic biology, and more.

Creationists and engineers do virtual battle...again.

A computer program from UVA aims to predict which cancer drug is best for each patient.

A blogger says the antiquated way that authorship order is decided for publications has to go.

A new application can browse the genome in interactive real-time.

Pages

An analysis appearing in PeerJ finds that social media mentions of a paper may lead to increased citations.

NIH's Michael Lauer looks at the number of grants, their amount, and funding success rates at the agency for last year.

At Nature, Johns Hopkins' Gundula Bosch describes her graduate program that aims to get doctoral students thinking about the big picture.

Patricia Fara writes about childcare funding, and women in science and science history at NPR.